As of September 2026 Avalyn Pharma has a market cap of NZ$2.45 Billion. This makes Avalyn Pharma the world's 5697th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 21st, 2026 the market cap of Avalyn Pharma was reported to be: